Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3367)
All Articles published online
|
Feb 7, 2006 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiang PH, Motoo Y, Garcia S, Iovanna JL, Pébusque MJ, Sawabu N. Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World J Gastroenterol 2006; 12(5): 691-696 [PMID: 16521180 DOI: 10.3748/wjg.v12.i5.691] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i5/691.htm |
| Number | Citing Articles |
| 1 |
Donna M. D'Agostino, Paola Zanovello, Toshiki Watanabe, Vincenzo Ciminale. . Advances in Cancer Research 2012; 113: 45 doi: 10.1016/B978-0-12-394280-7.00002-6
|
| 2 |
Kevin Beezhold, Jia Liu, Hong Kan, Terry Meighan, Vince Castranova, Xianglin Shi, Fei Chen. miR-190-Mediated Downregulation of PHLPP Contributes to Arsenic-Induced Akt Activation and Carcinogenesis. Toxicological Sciences 2011; 123(2): 411 doi: 10.1093/toxsci/kfr188
|
| 3 |
Mylene Seux, Juan lovanna, Jean-Charles Dagorn, Nelson J. Dusetti. MicroRNAs in Pancreatic Ductal Adenocarcinoma: New Diagnostic and Therapeutic Clues. Pancreatology 2009; 9(1-2): 66 doi: 10.1159/000178876
|
| 4 |
D. Taïeb, S. Giusiano, F. Sebag, M. Marcy, C. de Micco, F. F. Palazzo, N. J. Dusetti, J. L. Iovanna, J. F. Henry, S. Garcia, Colette Taranger‐Charpin. Tumor Protein p53‐Induced Nuclear Protein (TP53INP1) Expression in Medullary Thyroid Carcinoma: A Molecular Guide to the Optimal Extent of Surgery?. World Journal of Surgery 2010; 34(4): 830 doi: 10.1007/s00268-010-0395-6
|
| 5 |
Yulia Margolin‐Miller, Natalia Yanichkin, Keren Shichrur, Helen Toledano, Anat Ohali, Theophilos Tzaridis, Shalom Michowitz, Suzana Fichman‐Horn, Meora Feinmesser, Stefan M. Pfister, Hendrik Witt, Uri Tabori, Eric Bouffet, Vijay Ramaswamy, Cynthia Hawkins, Michael D. Taylor, Isaac Yaniv, Smadar Avigad. Prognostic relevance of miR‐124‐3p and its target TP53INP1 in pediatric ependymoma. Genes, Chromosomes and Cancer 2017; 56(8): 639 doi: 10.1002/gcc.22467
|
| 6 |
Wenhao Weng, Qinyuan Yang, Miaolong Huang, Yongxia Qiao, Yuan Xie, Yongchun Yu, An jing, Zhi Li. c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinoma. Biochemical and Biophysical Research Communications 2011; 405(2): 278 doi: 10.1016/j.bbrc.2011.01.028
|
| 7 |
Wei Ye, Fulv Liang, Chen Ying, Maolin Zhang, Dongbo Feng, Xinyu Jiang. Downregulation of microRNA‑3934‑5p induces apoptosis and inhibits the proliferation of neuroblastoma cells by targeting TP53INP1. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8007
|
| 8 |
Vanessa F. Bonazzi, Darryl Irwin, Nicholas K. Hayward. Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma. Genes, Chromosomes and Cancer 2009; 48(1): 10 doi: 10.1002/gcc.20615
|
| 9 |
FENG GAO, WENHUI WANG. MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a. Molecular Medicine Reports 2015; 11(2): 1200 doi: 10.3892/mmr.2014.2854
|
| 10 |
Sophie Giusiano, Stéphane Garcia, Claudia Andrieu, Nelson Javier Dusetti, Cyrille Bastide, Martin Gleave, Colette Taranger‐Charpin, Juan Lucio Iovanna, Palma Rocchi. TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse. The Prostate 2012; 72(2): 117 doi: 10.1002/pros.21412
|
| 11 |
Juan Iovanna, Ezequiel Luis Calvo, Jean Charles Dagorn, Nelson Dusetti. Diagnostic, Prognostic and Therapeutic Value of Gene Signatures. 2012; : 51 doi: 10.1007/978-1-61779-358-5_5
|
| 12 |
NAOKI NAKAYA, YASUHITO ISHIGAKI, HIDEO NAKAJIMA, MANABU MURAKAMI, TAKEO SHIMASAKI, TAKANOBU TAKATA, MAMORU OZAKI, NELSON J. DUSETTI, JUAN L. IOVANNA, YOSHIHARU MOTOO. Meaning of tumor protein 53-induced nuclear protein 1 in the molecular mechanism of gemcitabine sensitivity. Molecular and Clinical Oncology 2013; 1(1): 100 doi: 10.3892/mco.2012.8
|
| 13 |
Houda Saadi, Marion Seillier, Alice Carrier. The stress protein TP53INP1 plays a tumor suppressive role by regulating metabolic homeostasis. Biochimie 2015; 118: 44 doi: 10.1016/j.biochi.2015.07.024
|
| 14 |
Sophie Giusiano, Virginie Baylot, Claudia Andrieu, Ladan Fazli, Martin Gleave, Juan Lucio Iovanna, Colette Taranger‐Charpin, Stéphane Garcia, Palma Rocchi. TP53INP1 as new therapeutic target in castration‐resistant prostate cancer. The Prostate 2012; 72(12): 1286 doi: 10.1002/pros.22477
|
| 15 |
Tatiana S. Kalinina, Vladislav V. Kononchuk, Vladimir Y. Ovchinnikov, Mikhail D. Chanyshev, Lyudmila F. Gulyaeva. Expression of the miR-190 family is increased under DDT exposure in vivo and in vitro. Molecular Biology Reports 2018; 45(6): 1937 doi: 10.1007/s11033-018-4343-0
|
| 16 |
Mei Wang, Hongbing Gu, Hui Qian, Wei Zhu, Chonghui Zhao, Xu Zhang, Yang Tao, Ling Zhang, Wenrong Xu. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation. European Journal of Cancer 2013; 49(8): 2010 doi: 10.1016/j.ejca.2012.12.017
|
| 17 |
Houda Saadi, Marion Seillier, Maria José Sandi, Sylvain Peuget, Christine Kellenberger, Gwenaëlle Gravis, Nelson J. Dusetti, Juan L. Iovanna, Palma Rocchi, Mohamed Amri, Alice Carrier. Development of an ELISA detecting Tumor Protein 53-Induced Nuclear Protein 1 in serum of prostate cancer patients. Results in Immunology 2013; 3: 51 doi: 10.1016/j.rinim.2013.05.002
|
| 18 |
Giovanni Zarrilli, Francesca Galuppini, Valentina Angerilli, Giada Munari, Marianna Sabbadin, Vanni Lazzarin, Lorenzo Nicolè, Rachele Biancotti, Matteo Fassan. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma. International Journal of Molecular Sciences 2021; 22(7): 3640 doi: 10.3390/ijms22073640
|
| 19 |
Kai-Yu Ng, Lok-Hei Chan, Stella Chai, Man Tong, Xin-Yuan Guan, Nikki P Lee, Yunfei Yuan, Dan Xie, Terence K Lee, Nelson J Dusetti, Alice Carrier, Stephanie Ma. TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma. Cancer Research 2017; 77(17): 4602 doi: 10.1158/0008-5472.CAN-16-3456
|
| 20 |
Katia Ruggero, Alberto Corradin, Paola Zanovello, Alberto Amadori, Vincenzo Bronte, Vincenzo Ciminale, Donna M. D’Agostino. Role of microRNAs in HTLV-1 infection and transformation. Molecular Aspects of Medicine 2010; 31(5): 367 doi: 10.1016/j.mam.2010.05.001
|
| 21 |
Qian Wei, Yi‐Xuan Li, Min Liu, Xin Li, Hua Tang. MiR‐17‐5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life 2012; 64(8): 697 doi: 10.1002/iub.1051
|
| 22 |
Shuhua Wang, Fengxia Liu, Hui Ma, Xueling Cui, Shenghua Yang, Rui Qin. circCDYL Acts as a Tumor Suppressor in Triple Negative Breast Cancer by Sponging miR-190a-3p and Upregulating TP53INP1. Clinical Breast Cancer 2020; 20(5): 422 doi: 10.1016/j.clbc.2020.04.006
|
| 23 |
Christophe Regnault, Isabelle AM Worms, Christine Oger-Desfeux, Christelle MelodeLima, Sylvie Veyrenc, Marie-Laure Bayle, Bruno Combourieu, Aurélie Bonin, Julien Renaud, Muriel Raveton, Stéphane Reynaud. Impaired liver function in Xenopus tropicalis exposed to benzo[a]pyrene: transcriptomic and metabolic evidence. BMC Genomics 2014; 15(1) doi: 10.1186/1471-2164-15-666
|
| 24 |
Mingyang Jiang, Zhili Pei, Xiaojing Fan, Jingqing Jiang, Qinghu Wang, Zhifeng Zhang. Function Analysis of Human Protein Interactions Based on a Novel Minimal Loop Algorithm. Current Bioinformatics 2019; 14(2): 164 doi: 10.2174/1574893613666180906103946
|
| 25 |
Yetao Xu, Yifan Lian, Yuanyuan Zhang, Shiyun Huang, Qing Zuo, Nana Yang, Yanzi Chen, Dan Wu, Lizhou Sun. The long non‐coding RNA PVT1 represses ANGPTL4 transcription through binding with EZH2 in trophoblast cell. Journal of Cellular and Molecular Medicine 2018; 22(2): 1272 doi: 10.1111/jcmm.13405
|
| 26 |
Li Zhang, Xiaohong Sang, Yuanyuan Han, Alpati Abulitibu, Mufunayi Elken, Zhijie Mao, Shaotao Kang, Wenjun Yang, Chen Lu. The expression of apoptosis related genes in HK-2 cells overexpressing PPM1K was determined by RNA-seq analysis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1004610
|
| 27 |
Shuai-Shuai Shi, Hui-Peng Zhang, Chang-Qing Yang, Li-Na Li, Yu Shen, Yi-Qiang Zhang. Exosomal miR-155-5p promotes proliferation and migration of gastric cancer cells by inhibiting TP53INP1 expression. Pathology - Research and Practice 2020; 216(6): 152986 doi: 10.1016/j.prp.2020.152986
|
| 28 |
Chun-Mei Zhang, Jing Zhao, Hua-Yu Deng. MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1. Journal of Biomedical Science 2013; 20(1) doi: 10.1186/1423-0127-20-79
|
| 29 |
Bo Lu, Ian T. Christensen, Tao Yu, Chunxia Wang, Qichang Yan, Xinling Wang. SUMOylation Evoked by Oxidative Stress Reduced Lens Epithelial Cell Antioxidant Functions by Increasing the Stability and Transcription of TP53INP1 in Age-Related Cataracts. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/7898069
|
| 30 |
Feizhou Jiang, Te Liu, Yinyan He, Qin Yan, Xiaoyue Chen, Hui Wang, Xiaoping Wan. MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-425
|
| 31 |
Shalini Vellasamy, Chih Kong Tong, Nur Atiqah Azhar, Radha Kodiappan, Soon Choy Chan, Abhi Veerakumarasivam, Rajesh Ramasamy. Human mesenchymal stromal cells modulate T-cell immune response via transcriptomic regulation. Cytotherapy 2016; 18(10): 1270 doi: 10.1016/j.jcyt.2016.06.017
|
| 32 |
Makoto YAMAGISHI, Toshiki WATANABE. miRNA in HTLV-1 related Disease. Uirusu 2012; 62(1): 9 doi: 10.2222/jsv.62.9
|
| 33 |
Jennifer S. Bennetts, Nanna D. Rendtorff, Fiona Simpson, Lisbeth Tranebjaerg, Carol Wicking. The coding region of TP53INP2, a gene expressed in the developing nervous system, is not altered in a family with autosomal recessive non‐progressive infantile ataxia on chromosome 20q11‐q13. Developmental Dynamics 2007; 236(3): 843 doi: 10.1002/dvdy.21064
|
| 34 |
Nikolett Sándor, Boglárka Schilling-Tóth, Enikő Kis, Lili Fodor, Fruzsina Mucsányi, Géza Sáfrány, Hargita Hegyesi. TP53inp1 Gene Is Implicated in Early Radiation Response in Human Fibroblast Cells. International Journal of Molecular Sciences 2015; 16(10): 25450 doi: 10.3390/ijms161025450
|
| 35 |
A C West, K Tang, H Tye, L Yu, N Deng, M Najdovska, S J Lin, J J Balic, E Okochi-Takada, P McGuirk, B Keogh, W McCormack, P S Bhathal, M Reilly, M Oshima, T Ushijima, P Tan, B J Jenkins. Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer. Oncogene 2017; 36(36): 5134 doi: 10.1038/onc.2017.121
|
| 36 |
Jin Dou, Daoyuan Tu, Haijian Zhao, Xiaoyu Zhang. LncRNA PCAT18/miR-301a/TP53INP1 axis is involved in gastric cancer cell viability, migration and invasion. The Journal of Biochemistry 2020; 168(5): 547 doi: 10.1093/jb/mvaa079
|
| 37 |
GUOHUI NIE, HONGFANG DUAN, XIAOQING LI, ZHENDONG YU, LIANG LUO, RUIJING LU, ZILIANG JI, WEI ZHANG. MicroRNA-205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1. Molecular Medicine Reports 2015; 12(4): 5715 doi: 10.3892/mmr.2015.4181
|
| 38 |
Aijun Ren, Zhenzhen Wen, Liangjie Zheng. Downregulation of miR‑3934‑5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7718
|
| 39 |
Prudence N'guessan, Laurent Pouyet, Gaëlle Gosset, Sonia Hamlaoui, Marion Seillier, Carla E. Cano, Mylène Seux, Pierre Stocker, Marcel Culcasi, Juan L. Iovanna, Nelson J. Dusetti, Sylvia Pietri, Alice Carrier. Absence of Tumor Suppressor Tumor Protein 53-Induced Nuclear Protein 1 (TP53INP1) Sensitizes Mouse Thymocytes and Embryonic Fibroblasts to Redox-Driven Apoptosis. Antioxidants & Redox Signaling 2011; 15(6): 1639 doi: 10.1089/ars.2010.3553
|
| 40 |
Chunmei Zhang, Jing Zhao, Huayu Deng. 17β-Estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells. Molecular and Cellular Biochemistry 2013; 379(1-2): 201 doi: 10.1007/s11010-013-1642-6
|
| 41 |
Meritxell Gironella, Mylène Seux, Min-Jue Xie, Carla Cano, Richard Tomasini, Julien Gommeaux, Stephane Garcia, Jonathan Nowak, Man Lung Yeung, Kuan-Teh Jeang, Amandine Chaix, Ladan Fazli, Yoshiharu Motoo, Qing Wang, Palma Rocchi, Antonio Russo, Martin Gleave, Jean-Charles Dagorn, Juan L. Iovanna, Alice Carrier, Marie-Josèphe Pébusque, Nelson J. Dusetti. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proceedings of the National Academy of Sciences 2007; 104(41): 16170 doi: 10.1073/pnas.0703942104
|
| 42 |
Ernesto Orozco‐Lucero, Isabelle Dufort, Claude Robert, Marc‐André Sirard. Rapidly cleaving bovine two‐cell embryos have better developmental potential and a distinctive mRNA pattern. Molecular Reproduction and Development 2014; 81(1): 31 doi: 10.1002/mrd.22278
|
| 43 |
Elizabeth M. Cramer, Ying Shao, Yan Wang, Yan Yuan. miR-190 is upregulated in Epstein–Barr Virus type I latency and modulates cellular mRNAs involved in cell survival and viral reactivation. Virology 2014; : 184 doi: 10.1016/j.virol.2014.06.029
|
| 44 |
Qinchuan Li, Yang Han, Chunhong Wang, Shan Shan, Yuanyuan Wang, Jingang Zhang, Tao Ren. MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer. Cancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0233-x
|
| 45 |
Feng Zhi, Guangxin Zhou, Suinuan Wang, Yimin Shi, Ya Peng, Naiyuan Shao, Wei Guan, Hongtao Qu, Yi Zhang, Qiang Wang, Changchun Yang, Rong Wang, Sujia Wu, Xiwei Xia, Yilin Yang. A microRNA expression signature predicts meningioma recurrence . International Journal of Cancer 2013; 132(1): 128 doi: 10.1002/ijc.27658
|
| 46 |
Yan Deng, Ai-Min Li, Xin-Mei Zhao, Zhang-Juan Song, Si-De Liu. Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosis. Oncology Letters 2017; 13(3): 1228 doi: 10.3892/ol.2016.5537
|
| 47 |
Tae Young Ryu, In Hwan Tae, Tae-Su Han, Jinkwon Lee, Kwangho Kim, Yunsang Kang, Solbi Kim, Hyo Jin Lee, Cho-Rok Jung, Jung Hwa Lim, Dae-Soo Kim, Mi-Young Son, Hyun-Soo Cho. Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancer. Experimental Hematology & Oncology 2024; 13(1) doi: 10.1186/s40164-024-00554-y
|
| 48 |
Julien Gommeaux, Carla Cano, Stéphane Garcia, Meritxell Gironella, Sylvia Pietri, Marcel Culcasi, Marie-Josèphe Pébusque, Bernard Malissen, Nelson Dusetti, Juan Iovanna, Alice Carrier. Colitis and Colitis-Associated Cancer Are Exacerbated in Mice Deficient for Tumor Protein 53-Induced Nuclear Protein 1. Molecular and Cellular Biology 2007; 27(6): 2215 doi: 10.1128/MCB.01454-06
|
| 49 |
Mayumi Nishimoto, Sayaka Nishikawa, Naoto Kondo, Yumi Wanifuchi-Endo, Yukari Hato, Tomoka Hisada, Yu Dong, Katsuhiro Okuda, Hiroshi Sugiura, Hiroyuki Kato, Satoru Takahashi, Tatsuya Toyama. Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients. Japanese Journal of Clinical Oncology 2019; 49(6): 567 doi: 10.1093/jjco/hyz029
|
| 50 |
M Seux, S Peuget, M P Montero, C Siret, V Rigot, P Clerc, V Gigoux, E Pellegrino, L Pouyet, P N'Guessan, S Garcia, M Dufresne, J L Iovanna, A Carrier, F André, N J Dusetti. TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression. Oncogene 2011; 30(27): 3049 doi: 10.1038/onc.2011.25
|
| 51 |
Yi Wang, Huizhi Sun, Danfang Zhang, Dan Fan, Yanhui Zhang, Xueyi Dong, Shiqi Liu, Zhao Yang, Chunsheng Ni, Yanlei Li, Fang Liu, Xiulan Zhao. TP53INP1 inhibits hypoxia‐induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer. Journal of Cellular and Molecular Medicine 2018; 22(7): 3475 doi: 10.1111/jcmm.13625
|
| 52 |
Yasuhiro Ito, Yoshiharu Motoo, Hiroshi Yoshida, Juan Lucio Iovanna, Yasushi Nakamura, Kanji Kuma, Akira Miyauchi. High level of tumour protein p53-induced nuclear protein 1 (TP53INP1) expression in anaplastic carcinoma of the thyroid. Pathology 2006; 38(6): 545 doi: 10.1080/00313020601024094
|
| 53 |
Man Lung Yeung, Jun-ichirou Yasunaga, Yamina Bennasser, Nelson Dusetti, David Harris, Nafees Ahmad, Masao Matsuoka, Kuan-Teh Jeang. Roles for MicroRNAs, miR-93 and miR-130b, and Tumor Protein 53–Induced Nuclear Protein 1 Tumor Suppressor in Cell Growth Dysregulation by Human T-Cell Lymphotrophic Virus 1. Cancer Research 2008; 68(21): 8976 doi: 10.1158/0008-5472.CAN-08-0769
|
| 54 |
Stephanie Ma, Kwan Ho Tang, Yuen Piu Chan, Terence K. Lee, Pak Shing Kwan, Antonia Castilho, Irene Ng, Kwan Man, Nathalie Wong, Ka-Fai To, Bo-Jian Zheng, Paul B.S. Lai, Chung Mau Lo, Kwok Wah Chan, Xin-Yuan Guan. miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1. Cell Stem Cell 2010; 7(6): 694 doi: 10.1016/j.stem.2010.11.010
|